Ligand id: 9281

Name: fezakinumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9137 fezakinumab
Fezakinumab is a fully human monoclonal anti-IL22 antibody being investigated for clinical antiinflammatory utility against acute and chronic conditions.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. Peptide sequences identical to those of the heavy and light variable regions of fezakinumab are claimed in patent US7811567, leading to identification of clone 356A11 as fezakinumab [1].
Database Links
Specialist databases
IMGT/mAb-DB 323
Other databases
GtoPdb PubChem SID 318164800
Search PubMed clinical trials fezakinumab
Search PubMed titles fezakinumab
Search PubMed titles/abstracts fezakinumab